Abstract. Progranulin (PGRN) is a neurotrophic factor that regulates neurite outgrowth and enhances neuronal survival. The association between PGRN and neural stem cell (NSC) differentiation may aid in elucidating the underlying pathogenesis and potential treatments for neurodegenerative diseases. To investigate the association between PGRN and NSCs and their lineages, primary NSCs were prepared from the subventricular zone of neonatal Sprague Dawley pups (age, 1 day) and cultured in the neural stem cell medium. After 7 days in culture, NSCs aggregated into neurospheres and were maintained in the differential medium for 7 days following three passages. In addition, PGRN expression in neurospheres and differentiated cells (neurons, astrocytes and oligodendrocytes) were analyzed by immunocytochemistry. The PGRN expression and localization was also investigated in the brain tissues of neonatal rats (age, 1 and 7 days) by double immunofluorescence staining. The data indicated that PGRN was highly expressed in NSCs and their differentiated cell lineages in vitro. The results also demonstrated that PGRN was predominantly expressed in neurons and microglia in vivo, and marginally in NSCs, astrocytes and oligodendrocytes. The present study suggested that PGRN may be involved in the regulation of NSC differentiation.
Introduction
Progranulin (PGRN), also termed proepithelin, acrogranin or prostate cancer cell-derived growth factor, is a growth modulating factor involved in multiple biological functions (1) . The mutations within the PGRN gene result in the partial loss of the PGRN protein, which is the leading cause of frontotemporal lobar degeneration (FTLD) (2) . It was demonstrated that PGRN exhibited high expression levels during early neural development (3) . However, its expression was restricted to defined neuronal populations, including cortical and hippocampal pyramidal neurons and Purkinje cells in the adult brain (4) . Although the expression of PGRN in motor neurons and neuroblastoma cell lines has been investigated (5, 6) , the involvement of PGRN in the central nervous system (CNS) remains to be elucidated.
Neural stem cells (NSCs) are the undifferentiated neural cells that possess multi-potential and self-renewal capacity, and differentiate into three cell lineages in the CNS: neurons, astrocytes and oligodendrocytes (7, 8) . NSCs were predominantly separated and cultured from the subventricular zone (SVZ) of the lateral ventricles and subgranular zone (SGZ) of the hippocampus in the adult nervous system (9) . Investigation of the involvement of ectogenic and endogenic factors in NSCs aid in the understanding of how to modulate the proliferation and differentiation of NSCs during neurogenesis (10, 11) . Recent studies have demonstrated that PGRN is a neurotrophic factor that modulates neurite outgrowth and enhances neuronal survival (12) , and exogenous PGRN promotes neural progenitor cell proliferation (13) . However, the expression profiles of PGRN in neurospheres and its differentiated subpopulations are not fully understood.
Considering the essential role of NSCs in neurogenesis, further insight into the association between PGRN and NSCs may aid in the clarification of the involvement of PGRN in 
Differentiation of neural stem cells.
To induce the differentiation of NSCs, neurospheres were seeded onto poly-L-lysine-coated glass coverslips (NEST Biotechnology Co., Ltd., Shanghai, China) following three passages and then cultured in differentiation medium containing DMEM/F12 (1:1), 1% N2, and 10% fetal bovine serum (FBS) (Gibco-BRL). Under this environment, the sedimentary neurospheres attached to the poly-L-lysine-coated surface and began to differentiate into neurons, astrocytes and oligodendrocytes. The cells were maintained at 37˚C in a 5% CO 2 atmosphere and the medium was replaced every 2 days. The differentiation of NSCs was observed using a phase-contrast microscope (DMI4000B; Leica, Wetzlar, Germany), cells were photographed and analyzed for morphology at day 7.
Preparation of tissue sections. The brains of neonatal SD rats (age, 1 and 7 days) were used to investigate the expression and localization of PGRN during development. The rats were anesthetized with a peritoneal injection of 10% chloral hydrate (Sigma-Aldrich, St. Louis, MO, USA) and perfused transcardially with cold phosphate saline buffer (PBS) followed by ice-cold 4% paraformaldehyde in 0.1 M PBS. The brains were removed and postfixed in 4% paraformaldehyde solution at 4˚C overnight, after which the brains were dehydrated serially in 10, 20 and 30% sucrose in PBS overnight at 4˚C. When the the brain sediment reached the bottom of the tubes, the brains were embedded in Optimal Cutting Temperature compound (Sakura Finetek Co., Ltd., Tokyo, Japan). Serial coronal sections were cut using a freezing microtome at 10 µm and mounted onto poly-L-lysine-coated glass slides. PGRN was detected using immunohistochemistry.
Immunocytochemistry staining. To investigate the expression of PGRN in NSCs, the neurospheres were collected by centrifugation and then washed three times with PBS and fixed in 4% paraformaldehyde solution for 30 min at room temperature. Following three washes with PBS, the neurospheres were blocked using 10% normal goat serum for 1 h at room temperature to reduce non-specific binding. 
Double immunofluorescent staining.
The expression of PGRN was also detected in the brain of neonatal SD rats (age, 1 and 7 days). Frozen sections were heated to 56˚C for 10 min, washed with PBS and incubated with blocking solution with 10% normal goat serum containing 0.3% Triton X-100 for 1 h at room temperature. The sections were then incubated with primary antibodies (anti-PGRN, 1:600; anti-βIII-Tubulin, 1:1,000; anti-GFAP, 1:1,000; and anti-Oli, 1:1,000) overnight at 4˚C. When the sections had been thoroughly washed with PBS, appropriate secondary antibodies Alexa Flour 488 and Alexa Flour 594 (1:1,000 dilution, Invitrogen Life Technologies) were added and incubated for 2 h at 37˚C, and the sections were washed three times with PBS. Nuclei were stained with the nuclear dye Hoechst 33342 (20 ng/ml) for 5 min and rinsed with PBS, and the coverslips were mounted on slides with FluorSave reagent (Beyotime, Jiangsu, China).
Results

Neural stem cells aggregate into neurospheres and express PGRN.
Neurospheres were clearly observed at day 3. Numerous neurospheres proliferated in suspension at day 7 following primary culture (Fig. 1A) . Immunocytochemistry results showed that neurospheres appeared positive for nestin and PGRN expression ( Fig. 2A-D) . These results indicated that NSCs were successfully isolated and cultured and expressed PGRN.
NSC-derived subpopulations express PGRN.
After three passages, the neurospheres were transferred in 24-well plates containing poly-L-lysine-coated glass coverslips and were maintained in differential medium, containing DMEM/F12 (1:1), 1% N2 supplement and 10% FBS, for a further 7 days. The neurospheres began to attach to the coverslips and gradually showed the morphological features of neural cells (Fig. 1B) . The immunocytochemical staining showed that the NSCs differentiated into βIII-tubulin + neurons, GFAP (Fig. 1F-H) . Moreover, all NSC-derived cells expressed PGRN in vitro (Fig. 3) .
PGRN is expressed in neurons and microglia but marginally in NSCs, astrocytes and oligodendrocytes in the brains of neonatal rats.
The expression of PGRN was also analyzed by immunofluorescent staining in postnatal rat brains at day 1 (P1) and day 7 (P7). PGRN immunoreactivity was observed predominantly in the cortex, corpus callosum and hippocampus. To analyze the cell type-specific expression of PGRN in the neonatal brain, immunofluorescent double labeling was performed with specific markers for neurons (βIII-tubulin), astrocytes (GFAP), microglia (OX-42), NSCs (Nestin) and oligodendrocytes (Oli). The results indicated that the mature neuronal marker, βIII-tubulin (Fig. 4Aa-Ad) and microglia marker, OX-42 (Fig. 4Da-Dd) were double-labeled with PGRN, which indicated that PGRN was predominantly expressed in neurons and microglia during the early stages of rat brain development. By contrast, PGRN immunoreactivity was marginal in astrocytes ( Fig. 4Ab-Db) , NSCs ( Fig. 4Ca -Cd) and oligodendrocytes ( Fig. 4Ea-Ed) . Thus, these results suggest that PGRN was predominantly expressed in neurons and microglia rather than NSCs, astrocytes and oligodendrocytes in the brain at P1 and P7.
Discussion
Numerous studies have demonstrated that the 68.5-kDa secreted protein PGRN is a growth factor (14) , which functions as a potential mediator of wound healing and cancer progression (1). More recently, PGRN was suggested to be associated with neurodegenerative diseases and psychiosis (15, 16) . Mutations in the progranulin gene have been identified as a predominant cause of frontotemporal lobar degeneration with ubiquitin-positive inclusions (17) . Previous studies have indicated that the overexpression of PGRN was cytoprotective in cultured cells (5) and in vivo in transgenic mice (18) . PGRN was observed to be an endogenous neuroprotectant against apoptosis and inflammatory responses. Conversely, extracellular PGRN also acts as a neuroprotective factor in the regulation of neurite outgrowth, enhanced neuronal survival and protection against excitotoxicity and oxidative stress which leads to the exacerbation of neuronal cell death (12, 19) . Taken together, these results demonstrated that PGRN may be a therapeutic target for neurodegenerative diseases.
It was demonstrated that PGRN also enhances neural progenitor cell proliferation (13) . In the present study, the expression of PGRN was analyzed in NSCs cultured from the SVZ of neonatal rat brain and their differentiated cell lineages. The expression and cell location of PGRN was also detected in the neonatal rat brain. The results indicated that PGRN was abundantly expressed in neurospheres and their differentiated cell lineages. The in vivo studies showed that PGRN was highly expressed in neurons and microglia but only marginally in NSCs, astrocytes and oligodendrocytes in neonatal rat brain. These data provided useful information concerning the involvement of PGRN in the regulation of NSCs under the physiological conditions during development.
PGRN was identified in motor neurons, neuroblastoma cell lines and fibroblasts (5, 20, 21) . Our data indicated that PGRN may be important in regulating the differentiation of NSCs under physiological conditions during development. In the present study, the expression of PGRN was analyzed in NSCs in vitro, and the results showed that PGRN was co-expressed with nestin in the NSC cytosol during proliferation. The immunostaining for PGRN by different neural cell markers nestin, βIII-Tubulin, GFAP and Oli was also used to analyze the in vitro NSC differentiation. The in vivo studies suggested that PGRN was co-expressed with neuron and microglia markers, but not with markers of NSCs, astrocytes and oligodendrocytes. The differential PGRN expression between in vitro and in vivo studies may be due to the different environmental stimulus. The data also demonstrated the expression of PGRN in neurons increased during the cell maturation, whereas the expression level in microglia was dependent upon the activation state of the cells, as it was upregulated in microglia in response to excitotoxic injuries (22) . Astrocytes differentiated from in vitro NSCs exhibited a high level of PGRN, indicating that the astrocytes are a potential source for cell transplantation during the treatment of FTLD.
In conclusion, the present data suggest that PGRN is likely to be involved in regulating the differentiation of NSCs. PGRN expression may be altered following oxidative stress or other environmental stimuli. Therefore, further studies should focus on the mechanism underlying the regulation of the differentiation and maturation of NSCs and its subpopulations by PGRN during development.
